Ticker
NVO

Price
142.49
Stock movement down
-0.77 (-0.54%)
Company name
Novo Nordisk A/S
Exchange
(NYSE
,
Currency
USD
)
Sector
Healthcare >
Biotechnology
Market cap
641.16B
Ent value
786.27B
Price/Sales
3.62
Price/Book
7.68
Div yield
1.31%
Div growth
10.20%
Growth years
-
FCF payout
102.95%
Trailing P/E
11.55
Forward P/E
54.49
PEG
8.37
EPS growth
9.69%
1 year return
80.79%
3 year return
49.81%
5 year return
40.75%
10 year return
20.67%
Last updated: 2024-06-13

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

DIVIDENDS

Dividend yield - 5y

Loading...
Dividend yield data
Dividend per share1.86
Dividend yield1.31%
Payout frequencySemi-annual
Maximum yield3.16%
Average yield1.60%
Minimum yield0.62%
Discount to avg yield-22.64%
Upside potential-18.46%
Yield as % of max yield41.24%

Yield distribution (inverse percentile) - 5y

Loading...
Yield distribution data
Dividend yield1.31%
Current yield distribution63.97%
Yield at 100% (Min)0.62%
Yield at 90%0.83%
Yield at 80%0.92%
Yield at 50% (Median)1.42%
Yield at 20%2.57%
Yield at 10%2.74%
Yield at 0% (Max)3.16%

Dividend per share

Loading...
Dividend per share data
Years of growth-
CCC status-
Dividend per share1.86
Payout frequencySemi-annual
Ex-div date22 Mar 2024
EPS (TTM)12.24
EPS (1y forward)2.62
EPS growth (5y)9.69%
EPS growth (5y forward)1.38%

Dividend growth

Loading...
Please create a free account or log in to access this chart
Dividend growth data
NVOS&P500
DGR MR110.48%-16.32%
DGR TTM107.06%4.05%
DGR 3 years2.61%5.24%
DGR 5 years10.20%5.40%
DGR 10 years13.72%7.07%
DGR 15 years17.11%6.12%
Time since last change announced138 days
EPS growth (5y)9.69%
EPS growth (5y forward)1.38%

Payout ratio

Loading...
Please create a free account or log in to access this chart
Payout ratio data
EPS coverageFCF coverage
TTM119.40%102.95%
Average--
Forward71.12%-

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E11.55
Price to OCF8.13
Price to FCF9.96
Price to EBITDA8.37
EV to EBITDA10.27

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales3.62
Price to Book7.68
EV to Sales4.44

FINANCIALS

Per share

Loading...
Per share data
Current share count4.50B
EPS (TTM)12.24
FCF per share (TTM)14.19

Income statement

Loading...
Income statement data
Revenue (TTM)176.95B
Gross profit (TTM)148.51B
Operating income (TTM)74.81B
Net income (TTM)55.52B
EPS (TTM)12.24
EPS (1y forward)2.62

Margins

Loading...
Margins data
Gross margin (TTM)83.92%
Operating margin (TTM)42.28%
Profit margin (TTM)31.38%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash12.65B
Net receivables57.51B
Total current assets108.19B
Goodwill5.09B
Intangible assets46.32B
Property, plant and equipment0.00
Total assets241.26B
Accounts payable15.59B
Short/Current long term debt25.78B
Total current liabilities120.94B
Total liabilities157.77B
Shareholder's equity83.49B
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)78.89B
Capital expenditures (TTM)14.75B
Free cash flow (TTM)64.39B
Dividends paid (TTM)66.30B

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity66.51%
Return on Assets23.01%
Return on Invested Capital52.52%
Cash Return on Invested Capital60.91%

iO Charts is a Seeking Alpha partner

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open142.83
Daily high142.91
Daily low141.14
Daily Volume2.85M
All-time high143.63
1y analyst estimate76.25
Beta0.31
EPS (TTM)12.24
Dividend per share1.86
Ex-div date22 Mar 2024
Next earnings date7 Aug 2024

Downside potential

Loading...
Downside potential data
NVOS&P500
Current price drop from All-time high-0.79%-
Highest price drop-51.74%-56.47%
Date of highest drop5 Aug 20029 Mar 2009
Avg drop from high-10.97%-11.29%
Avg time to new high15 days13 days
Max time to new high1120 days1805 days

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

COMPANY DETAILS
NVO (Novo Nordisk A/S) company logo
Marketcap
641.16B
Marketcap category
Large-cap
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Gilead Sciences, Inc. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
Employees
54393
Investor relations
SEC filings
CEO
Lars Fruergaard Joergensen
Country
USA
City
Novo Alle
Stock type
American depositary share
CCC status
-
Dividend Frequency
Semi-annual
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...

iO Charts is a Seeking Alpha partner

UNDERSTAND THE BUSINESS
Loading...